Eli Lilly and Company
Patents, Design & Utilities

Last updated:

List of all Eli Lilly and Company patents 385 in total

Status Patent
Application
Utility: ACYLATED INSULIN COMPOUND External link
Filling date: 18 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: PYRROLIDINONE COMPOUNDS External link
Filling date: 18 Sep 2025 Issue date: 14 Nov 2019
Grant
Utility: Amino pyrimidine compounds useful as SSAO inhibitors External link
Filling date: 18 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: (E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-- carboxylate for inhibiting CDK7 External link
Filling date: 18 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: IL-17 antibody formulations and methods of treatment using same External link
Filling date: 18 Sep 2025 Issue date: 12 Nov 2019
Application
Utility: COMBINATION OF RAMUCIRUMAB AND MERESTINIB FOR USE IN TREATMENT OF COLORECTAL CANCER External link
Filling date: 18 Sep 2025 Issue date: 7 Nov 2019
Grant
Utility: Amino pyrimidine SSAO inhibitors External link
Filling date: 18 Sep 2025 Issue date: 5 Nov 2019
Application
Utility: INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL External link
Filling date: 18 Sep 2025 Issue date: 31 Oct 2019
Application
Utility: DOPAMINE D1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS External link
Filling date: 18 Sep 2025 Issue date: 24 Oct 2019
Grant
Utility: Notch pathway signaling inhibitor compounds External link
Filling date: 18 Sep 2025 Issue date: 22 Oct 2019
Application
Utility: MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM External link
Filling date: 18 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: GROWTH DIFFERENTIATION FACTOR 15 AGONIST COMPOUNDS AND METHODS OF USING THE SAME External link
Filling date: 18 Sep 2025 Issue date: 10 Oct 2019
Grant
Utility: Inhibiting the transient receptor potential A1 ion channel External link
Filling date: 18 Sep 2025 Issue date: 1 Oct 2019
Application
Utility: Methods for Producing Fabs and IgG Bispecific Antibodies External link
Filling date: 18 Sep 2025 Issue date: 26 Sep 2019
Application
Utility: MUTANT IDH1 INHIBITORS External link
Filling date: 18 Sep 2025 Issue date: 26 Sep 2019
Grant
Utility: Inactivation of viruses by delipidation External link
Filling date: 18 Sep 2025 Issue date: 24 Sep 2019
Application
Utility: NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA External link
Filling date: 18 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: ANTI-RANKL ANTIBODIES AND USES THEREOF External link
Filling date: 18 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: AMINO PYRIMIDINE SSAO INHIBITORS External link
Filling date: 18 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: AMINO PYRIMIDINE COMPOUNDS USEFUL AS SSAO INHIBITORS External link
Filling date: 18 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: ANTI-TIM-3 ANTIBODIES FOR COMBINATION WITH ANTI-PD-1 ANTIBODIES External link
Filling date: 18 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: PD-1 AGONIST ANTIBODIES AND USES THEREOF External link
Filling date: 18 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: COMBINATION THERAPY WITH MERESTINIB AND ANTI-PD-L1 OR ANTI-PD-1 INHIBITORS FOR USE IN THE TREATMENT OF CANCER External link
Filling date: 18 Sep 2025 Issue date: 5 Sep 2019
Grant
Utility: Acylated insulin compound External link
Filling date: 18 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: 1,4-Oxazines useful as selective BACE1 inhibitors External link
Filling date: 18 Sep 2025 Issue date: 3 Sep 2019
Application
Utility: ANTI-TRKA ANTIBODY External link
Filling date: 18 Sep 2025 Issue date: 29 Aug 2019
Grant
Utility: Sensing system for detecting a piston in a medical fluid container External link
Filling date: 18 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: 5-methyl-1,3,4-oxadiazol-2-yl compounds External link
Filling date: 18 Sep 2025 Issue date: 13 Aug 2019
Application
Utility: MEDICATION DELIVERY DEVICE WITH MECHANICAL LOCKING SYSTEM External link
Filling date: 18 Sep 2025 Issue date: 8 Aug 2019
Grant
Utility: Cyclobutyl-imidazolidinone compounds External link
Filling date: 18 Sep 2025 Issue date: 6 Aug 2019
Application
Utility: RAPID-ACTING INSULIN COMPOSITIONS External link
Filling date: 18 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: Combination Therapy External link
Filling date: 18 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: TARGETED TREATMENT OF MATURE T-CELL LYMPHOMA External link
Filling date: 18 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: IL-21 ANTIBODIES AND USES THEREOF External link
Filling date: 18 Sep 2025 Issue date: 1 Aug 2019
Grant
Utility: Needle shield puller cap assembly External link
Filling date: 18 Sep 2025 Issue date: 30 Jul 2019

Showing 350 to 385 of 385 patents.